Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial.
- Published In:
- The lancet. Gastroenterology & hepatology, 8(6), 511-522 (2023)
- Authors:
- Loomba, Rohit(5), Abdelmalek, Manal F, Armstrong, Matthew J, Jara, Maximilian, Kjær, Mette Skalshøi, Krarup, Niels, Lawitz, Eric, Ratziu, Vlad, Sanyal, Arun J, Schattenberg, Jörn M, Newsome, Philip N
- Database ID:
- RPEP-07132
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07132APA
Loomba, Rohit; Abdelmalek, Manal F; Armstrong, Matthew J; Jara, Maximilian; Kjær, Mette Skalshøi; Krarup, Niels; Lawitz, Eric; Ratziu, Vlad; Sanyal, Arun J; Schattenberg, Jörn M; Newsome, Philip N. (2023). Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial.. The lancet. Gastroenterology & hepatology, 8(6), 511-522. https://doi.org/10.1016/S2468-1253(23)00068-7
MLA
Loomba, Rohit, et al. "Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial.." The lancet. Gastroenterology & hepatology, 2023. https://doi.org/10.1016/S2468-1253(23)00068-7
RethinkPeptides
RethinkPeptides Research Database. "Semaglutide 2·4 mg once weekly in patients with non-alcoholi..." RPEP-07132. Retrieved from https://rethinkpeptides.com/research/loomba-2023-semaglutide-24-mg-once
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.